Michael Scolaro

Michael Scolaro

Oct 28, 2017

Group 6 Copy 52
1
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Are climate change and air pollution triggering cardiovascular disease?

Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...

Development of non-invasive diagnostics for endotheliotropic herpesvirus in free-ranging Asian elephants

Elephant endotheliotropic herpes virus hemorrhagic disease (EEHV-HD) is the leading cause of death of young...

How does taking Ritalin affect depersonalization-derealization disorder patients?

We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

Backer Badge Funded